MicroRNA Expression Profile in Acute Ischemic Stroke
International Journal of Molecular Sciences · 17.01.2025 · 26 (2) · 747
DOI: 10.3390/ijms26020747 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.01.2025. Verfasst von Shraddha Mainali und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Virginia Commonwealth University, Richmond, VA 23298, USA. Hauptthemen laut MEDLINE: Ischemic Stroke, MicroRNAs. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, Ohio State University Neuroscience Research Institute.
Themen: Schlaganfall
Abstract (Originalsprache)
Acute ischemic stroke with large vessel occlusion (LVO) continues to present a considerable challenge to global health, marked by substantial morbidity and mortality rates. Although definitive diagnostic markers exist in the form of neuroimaging, their expense, limited availability, and potential for diagnostic delay can often result in missed opportunities for life-saving interventions. Despite several past attempts, research efforts to date have been fraught with challenges likely due to multiple factors, such as the inclusion of diverse stroke types, variable onset intervals, differing pathobiologies, and a range of infarct sizes, all contributing to inconsistent circulating biomarker levels. In this context, microRNAs (miRNAs) have emerged as a promising biomarker, demonstrating potential as biomarkers across various diseases, including cancer, cardiovascular conditions, and neurological disorders. These circulating miRNAs embody a wide spectrum of pathophysiological processes, encompassing cell death, inflammation, angiogenesis, neuroprotection, brain plasticity, and blood–brain barrier integrity. This pilot study explores the utility of circulating exosome-enriched extracellular vesicle (EV) miRNAs as potential biomarkers for anterior circulation LVO (acLVO) stroke. In our longitudinal prospective cohort study, we collected data from acLVO stroke patients at four critical time intervals post-symptom onset: 0–6 h, 6–12 h, 12–24 h, and 5–7 days. For comparative analysis, healthy individuals were included as control subjects. In this study, extracellular vesicles (EVs) were isolated from the plasma of participants, and the miRNAs within these EVs were profiled utilizing the NanoString nCounter system. Complementing this, a scoping review was conducted to examine the roles of specific miRNAs such as miR-140-5p, miR-210-3p, and miR-7-5p in acute ischemic stroke (AIS). This review involved a targeted PubMed search to assess their influence on crucial pathophysiological pathways in AIS, and their potential applications in diagnosis, treatment, and prognosis. The review also included an assessment of additional miRNAs linked to stroke. Within the first 6 h of symptom onset, three specific miRNAs (miR-7-5p, miR-140-5p, and miR-210-3p) exhibited significant differential expression compared to other time points and healthy controls. These miRNAs have previously been associated with neuroprotection, cellular stress responses, and tissue damage, suggesting their potential as early markers of acute ischemic stroke. This study highlights the potential of circulating miRNAs as blood-based biomarkers for hyperacute acLVO ischemic stroke. However, further validation in a larger, risk-matched cohort is required. Additionally, investigations are needed to assess the prognostic relevance of these miRNAs by linking their expression profiles with radiological and functional outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Department of Internal Medicine, Maharajgunj Medical Campus, Tribhuvan University, Kathmandu 44600, Nepal.
- Department of Neurosurgery, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Biomedical Informatics Shared Resources, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
- Genomics Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
- College of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
ORCID-Profile: Shraddha Mainali, Kirill Shumilov, Bradford B Worrall, Nicholas Johnson
Förderung
- NCATS NIH HHS
- Ohio State University Neuroscience Research Institute
Zitieren
APA
Mainali, S., Nepal, G., Shumilov, K., Webb, A., Fadda, P., Mirebrahimi, D., Hamed, M., Nana-Sinkam, P., Worrall, B. B., Woo, D., & Johnson, N. (2025). MicroRNA Expression Profile in Acute Ischemic Stroke. International Journal of Molecular Sciences, 26(2), 747. https://doi.org/10.3390/ijms26020747
Vancouver
Mainali S, Nepal G, Shumilov K, Webb A, Fadda P, Mirebrahimi D, et al. MicroRNA Expression Profile in Acute Ischemic Stroke. International Journal of Molecular Sciences. 2025;26(2):747. doi:10.3390/ijms26020747
BibTeX
@article{Mainali2025,
author = {Mainali, Shraddha and Nepal, Gaurav and Shumilov, Kirill and Webb, Amy and Fadda, Paolo and Mirebrahimi, Darya and Hamed, Mohammad and Nana-Sinkam, Patrick and Worrall, Bradford B and Woo, Daniel and Johnson, Nicholas},
title = {MicroRNA Expression Profile in Acute Ischemic Stroke},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {2},
pages = {747},
doi = {10.3390/ijms26020747}
}
EUVIMED